Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Equity Income (2022 - 2025)

INVO Fertility has reported Equity Income over the past 4 years, most recently at $12827.0 for Q3 2025.

  • Quarterly Equity Income rose 146.86% to $12827.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $26479.0 through Sep 2025, up 234.51% year-over-year, with the annual reading at $9045.0 for FY2024, 115.01% up from the prior year.
  • Equity Income was $12827.0 for Q3 2025 at INVO Fertility, up from -$19911.0 in the prior quarter.
  • Over five years, Equity Income peaked at $18467.0 in Q4 2024 and troughed at -$117978.0 in Q2 2022.
  • The 4-year median for Equity Income is -$2187.5 (2023), against an average of -$11054.1.
  • Year-over-year, Equity Income crashed 381.4% in 2023 and then skyrocketed 371.12% in 2024.
  • A 4-year view of Equity Income shows it stood at $10007.0 in 2022, then crashed by 381.4% to -$28160.0 in 2023, then soared by 165.58% to $18467.0 in 2024, then crashed by 30.54% to $12827.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Equity Income are $12827.0 (Q3 2025), -$19911.0 (Q2 2025), and $15096.0 (Q1 2025).